Lupkynis (voclosporin) - Aurinia Pharma
VOCAL-EXT: Long-Term Voclosporin Treatment in Adolescent Subjects with Lupus Nephritis (clinicaltrials.gov) - Aug 30, 2024 - P3 | N=40 | Enrolling by invitation | Sponsor: Aurinia Pharmaceuticals Inc. | Not yet recruiting ➔ Enrolling by invitation 
Enrollment open • Glomerulonephritis • Immunology • Inflammatory Arthritis • Lupus • Lupus Nephritis • Nephrology
http://clinicaltrials.gov/ct2/show/NCT05962788
 
Aug 30, 2024
 
Prev Next